PubRank

Paula M Cannon

Author PubWeight™ 33.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010 6.55
2 Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol 2005 1.97
3 HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010 1.87
4 New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J Virol 2007 1.69
5 Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 2002 1.67
6 Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther 2013 1.49
7 Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide. J Virol 2003 1.48
8 Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol 2010 1.47
9 Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 2010 1.40
10 Receptor use by pathogenic arenaviruses. Virology 2006 1.27
11 Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology 2011 1.14
12 Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release. J Virol 2006 1.12
13 Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther 2009 1.08
14 Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity. Virology 2007 1.04
15 Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts. J Virol 2012 1.02
16 Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J Virol 2011 1.00
17 Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. J Infect Dis 2013 0.97
18 Receptor use by the Whitewater Arroyo virus glycoprotein. Virology 2007 0.93
19 Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential. Hum Gene Ther 2007 0.89
20 Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins. J Virol 2009 0.86
21 Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype). Virus Res 2002 0.85
22 Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors. Retrovirology 2010 0.85
23 Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. J Virol 2009 0.84
24 A systems biology starter kit for arenaviruses. Viruses 2012 0.75